A Study Evaluating the Use of ResAppDx v2.0 as an Aid to Diagnose Respiratory Disease in Adolescent and Adult Patients in an Emergency Department

NCT06156462 · clinicaltrials.gov ↗

COMPLETED

Status

171

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma Exacerbation
COPD Exacerbation
Lower Respiratory Disease
Pneumonia

Interventions

DEVICE: ResAppDx v.20

Sponsor

ResApp Health Limited